Altai Protocol Library New Protocol: Durvalumab – Olaparib for Ovarina Cancer U. Darda Bayraktar, MD 2026-04-09
Altai Protocol Library New Indication: Datopotamab deruxtecan for Untreated Metastatic Triple-Negative Breast Cancer U. Darda Bayraktar, MD 2026-04-09
Altai Protocol Library New Protocol: Adjuvant Atezolizumab in dMMR Colon Cancer U. Darda Bayraktar, MD 2026-04-09
Altai Protocol Library New Protocol: Cytarabine – MitoXANtrone – Venetoclax for Rel/Ref AML U. Darda Bayraktar, MD 2026-03-12
Altai Protocol Library New Indication: Adjuvant Trastuzumab Deruxtecan for Residual Her2-Positive Breast Cancer U. Darda Bayraktar, MD 2026-03-12
Altai Protocol Library New Reference: Tislelizumab with Chemotherapy for Nasopharyngeal Carcinoma U. Darda Bayraktar, MD 2026-03-12
Altai Protocol Library New Protocol: Teclistamab with Daratumumab for Rel/Ref Multiple Myeloma U. Darda Bayraktar, MD 2026-03-12
Altai Protocol Library New Drug: Pivekimab Sunirine for Blastic Plasmacytoid Dendritic Cell Neoplasm U. Darda Bayraktar, MD 2026-03-12
Altai Protocol Library New Reference: Long Term Survival with Nivolumab-Ipilimumab in Advanced RCC U. Darda Bayraktar, MD 2026-03-12
Altai Protocol Library New Protocol: Neoadjuvant GOLP for Cholangiocarcinoma U. Darda Bayraktar, MD 2026-03-12
